LXRX earnings: real EPS beat/miss history, analyst consensus Hold, P/E -31.51. Updated 2026-07-23.
Lexicon Pharmaceuticals (LXRX) Research Hub
Lexicon Pharmaceuticals (LXRX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2 USD (-6.98%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -31.51, market cap 0.98B. This hub links to the full technical, earnings and options research available for LXRX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2 USD (-6.98%) |
| 52-week range | 1.92 USD – 2.68 USD |
| Trend regime | Range |
| 14-day RSI | 21.7 (Oversold) |
| Trailing P/E | -31.51 |
| Market cap | 0.98B |
| Dividend yield | 0.00% |
Available research for LXRX
Covered Call on LXRX: how it works, illustrative setup around the real 2 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LXRX: how it works, illustrative setup around the real 2 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LXRX: how it works, illustrative setup around the real 2 USD price, max profit/loss, breakeven and when to use it. Educational.
LXRX technical analysis: range, last 2 USD, RSI 21.7, 52w range 1.92 USD–2.68 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LXRX in?
Lexicon Pharmaceuticals (LXRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is LXRX in an uptrend or downtrend?
As of 2026-09-11, LXRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LXRX's trailing P/E ratio?
LXRX's trailing P/E is -31.51, with a market cap of 0.98B. See the earnings research page for full valuation detail.